InfuSystem (NYSE:INFU) CFO Buys $18,906.24 in Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry Steele acquired 2,064 shares of the stock in a transaction dated Monday, March 2nd. The stock was bought at an average price of $9.16 per share, for a total transaction of $18,906.24. Following the completion of the purchase, the chief financial officer owned 88,000 shares in the company, valued at approximately $806,080. This trade represents a 2.40% increase in their position. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.

InfuSystem Trading Up 4.6%

Shares of INFU opened at $9.60 on Thursday. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The stock has a market cap of $195.23 million, a PE ratio of 160.03 and a beta of 1.67. InfuSystem Holdings, Inc. has a 1 year low of $4.61 and a 1 year high of $11.04. The stock has a 50 day simple moving average of $8.42 and a 200-day simple moving average of $9.32.

Hedge Funds Weigh In On InfuSystem

Several institutional investors have recently bought and sold shares of INFU. Minerva Advisors LLC grew its holdings in shares of InfuSystem by 5.2% during the fourth quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company’s stock worth $9,676,000 after purchasing an additional 52,942 shares during the last quarter. Vanguard Group Inc. lifted its position in InfuSystem by 1.9% during the 3rd quarter. Vanguard Group Inc. now owns 976,177 shares of the company’s stock worth $10,113,000 after buying an additional 18,539 shares in the last quarter. Punch & Associates Investment Management Inc. lifted its position in InfuSystem by 1.9% during the 4th quarter. Punch & Associates Investment Management Inc. now owns 824,750 shares of the company’s stock worth $7,398,000 after buying an additional 15,000 shares in the last quarter. Renaissance Technologies LLC grew its holdings in InfuSystem by 2.0% during the 4th quarter. Renaissance Technologies LLC now owns 587,509 shares of the company’s stock worth $5,270,000 after acquiring an additional 11,795 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in InfuSystem by 0.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 569,238 shares of the company’s stock valued at $5,898,000 after acquiring an additional 4,430 shares in the last quarter. Institutional investors own 71.13% of the company’s stock.

Analysts Set New Price Targets

Separately, Roth Mkm reaffirmed a “buy” rating and issued a $15.00 target price (up from $14.00) on shares of InfuSystem in a report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $15.00.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.